Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V2’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
Type:
Grant
Filed:
April 10, 2020
Date of Patent:
April 12, 2022
Assignee:
GenCann, LLC
Inventors:
Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V3’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
Type:
Grant
Filed:
April 10, 2020
Date of Patent:
April 12, 2022
Assignee:
GenCann, LLC
Inventors:
Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
Abstract: The unique annual herbaceous Cannabis plant variety C. sativa ‘V1’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
Type:
Grant
Filed:
April 10, 2020
Date of Patent:
April 12, 2022
Assignee:
GenCann, LLC
Inventors:
Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
Abstract: The new Cannabis plant variety C. sativa ‘V3’ is provided. ‘V3’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin (THCV).
Type:
Grant
Filed:
August 5, 2019
Date of Patent:
June 29, 2021
Assignee:
GenCann, LLC
Inventors:
Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
Abstract: The new Cannabis plant variety ‘V2’ is provided. ‘V2’ is intended for use as medicinal herb for sale in Cannabis dispensaries for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin.
Type:
Grant
Filed:
August 5, 2019
Date of Patent:
June 29, 2021
Assignee:
GenCann, LLC
Inventors:
Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
Abstract: The new Cannabis plant variety ‘V1’ is provided. ‘V1’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin (THCV) to a greater amount by percent weight than tetrahydrocannabinol (THC).
Type:
Grant
Filed:
August 5, 2019
Date of Patent:
June 29, 2021
Assignee:
GenCann, LLC
Inventors:
Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong